Abstract
A chemoenzymatic strategy is introduced whereby a glycan backbone is assembled enzymatically to give a core oligosaccharide that is subjected to chemical manipulations to install terminal epitopes. A library of oligosaccharides
containing the human natural killer-1 epitope was synthesized, enabling evaluation of the binding specificities of serum antibodies of patients with anti-myelin-
associated glycoprotein neuropathy.
containing the human natural killer-1 epitope was synthesized, enabling evaluation of the binding specificities of serum antibodies of patients with anti-myelin-
associated glycoprotein neuropathy.
| Original language | English |
|---|---|
| Pages (from-to) | 15-16 |
| Number of pages | 2 |
| Journal | Nature Synthesis |
| Volume | 3 |
| Issue number | 1 |
| Early online date | 2 Oct 2023 |
| DOIs | |
| Publication status | Published - Jan 2024 |
Fingerprint
Dive into the research topics of 'Synthetic glycans provide insight into the binding properties of toxic serum antibodies'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver